Boston biotech Albireo Pharma Inc. went public Thursday through a reverse merger in which it acquired the stock listing of a Connecticut company.
Growth Capitalist (https://growthcapitalist.com/2016/11/nine-stories-you-may-have-missed-thursday-from-the-world-of-business/)
Boston biotech Albireo Pharma Inc. went public Thursday through a reverse merger in which it acquired the stock listing of a Connecticut company.